Biotechnology
International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk
MILAN and BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, accordin...
2019-09-03 07:44
3292
Syntellix Asia and Chunli Agree Far-reaching Co-operation to Introduce and Market Innovative "Quantum Leap in Implantology" MAGNEZIX® Medtech Devices in China
- Milestone contract signed between leading Chinese orthopaedic medtech supplier andSingapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery - Contract volume of more than 100 mi...
2019-08-30 22:28
2662
DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds
NEW YORK, Aug. 30, 2019 /PRNewswire/ -- DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation ("Celgene") to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and ...
2019-08-30 01:59
3235
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India
WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam,In...
2019-08-29 20:04
2750
Esco Ventures Announces the Launch of Carmine Therapeutics, a Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies
SINGAPORE, Aug. 29, 2019 /PRNewswire/ -- Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of ProfessorsMinh Le and Jiahai Shi at the CityUniversity of Hong Kong. Carmine Therape...
2019-08-29 11:00
2207
Innovent Reports Interim Results for Fiscal Year 2019
SUZHOU, China, Aug. 29, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced its interim financial results for the six months endedJune 30, 2019. HIGHLIGHTS AND OTH...
2019-08-29 08:39
3360
Ascletis Received IND Approval for its NASH Drug
HANGZHOU, China and SHAOXING, China, Aug. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that toget...
2019-08-28 08:00
3882
LBB Specialties Announces Strategic Partnership With MEGGLE On US Distribution Of Excipient Products
NORWALK, Connecticut, Aug. 28, 2019 /PRNewswire/ -- LBB Specialties announced that effectiveAugust 1, 2019, LBB has entered into a strategic partnership with MEGGLE Excipients & Technology to distribute MEGGLE's excipient products to companies in the American pharmaceutical and nutraceutical indu...
2019-08-28 06:00
2019
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million ) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...
2019-08-28 04:16
9159
DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration
SALT LAKE CITY, Aug. 27, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that the U.S. Food and Drug ...
2019-08-27 07:00
2150
Atonarp Inc. Announces $33 Million Series C Funding Round Completion
- Financing round brings five new investors to Atonarp, including Japan Post Investment Corporation and SBI Investment Co., Ltd. - Series C was oversubscribed as investor demand was driven by the company's accelerating development progress of disruptive healthcare diagnostics platform. - Fundin...
2019-08-26 07:00
2826
Gencurix's Study Explores the Difference between GenesWell BCT and Oncotype DX
SEOUL, South Korea, Aug. 23, 2019 /PRNewswire/ -- Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study onFrontiers in Oncology comparing GenesWell(TM) BCT, a prognostic multigene test, with Genomic Health's Oncotype DX in patients with early-stage breast cance...
2019-08-23 08:00
2740
Voronoi selects CDD Vault platform to manage its Drug Discovery Data
INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collabora...
2019-08-23 06:36
4357
Biotech Conagen Acquires Production Platform of Therapeutic Proteins
The technology should reduce costs to patients and accelerate drug development BEDFORD, Massachusetts, Aug. 22, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located inBoston's biotech corridor, announced today that it has acquired a fermentation-based technolo...
2019-08-22 01:39
2738
CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody
* This agreement represents the first strategic cooperation between two of the key players in biopharmaceutical industries in Suzhou,China * ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients wi...
2019-08-21 21:35
4518
Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results
HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 onTuesday, August 27, 2019, after the market close. The Company will host a conference call at 8:00 a.m....
2019-08-21 19:00
7629
NeuroVive Pharmaceutical AB Interim Report January - June 2019
STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important events April - June * The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. * The Supreme Court delivers it...
2019-08-21 15:24
7841
Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones
Customers Choose from a Wider Spectrum of Flavor Profiles BOSTON, Aug. 13, 2019 /PRNewswire/ -- Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalact...
2019-08-13 03:47
3326
Higher Levels of Automation Expand Revenue Potential for Analytical Instrumentation Manufacturers
Pharmaceuticals, biotechnology, and academics emerge major adopters of analytical equipment, finds Frost & Sullivan SANTA CLARA, California, Aug. 13, 2019 /PRNewswire/ -- The rise of the Industrial Internet of Things (IIoT) has given a significant boost to the global analytical instrumentation ma...
2019-08-13 00:19
2409
OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial
STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial p...
2019-08-09 14:57
2130
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 316 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 309 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 295 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
15019
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10431
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9812
